Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Future Microbiol ; 13: 1271-1281, 2018 09.
Article in English | MEDLINE | ID: mdl-30238771

ABSTRACT

AIM: To evaluate the effect on the nonsteroidal anti-inflammatory drug indomethacin on Clostridium difficile infection (CDI) severity. MATERIALS & METHODS: Indomethacin was administered in two different mouse models of antibiotic-associated CDI in two different facilities, using a low and high dose of indomethacin. RESULTS: Indomethacin administration caused weight loss, increased the signs of severe infection and worsened histopathological damage, leading to 100% mortality during CDI. Indomethacin-treated, antibiotic-exposed mice infected with C. difficile had enhanced intestinal inflammation with increased expression of KC, IL-1ß and IL-22 compared with infected mice unexposed to indomethacin. CONCLUSION: These results demonstrate a negative impact of nonsteroidal anti-inflammatory drugs on antibiotic-associated CDI in mice and suggest that targeting the synthesis or signaling of prostaglandins might be an approach to ameliorating the severity of CDI.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Clostridioides difficile , Clostridium Infections/drug therapy , Clostridium Infections/pathology , Indomethacin/adverse effects , Intestines/pathology , Severity of Illness Index , Animals , Anti-Bacterial Agents/adverse effects , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Disease Models, Animal , Indomethacin/administration & dosage , Interleukin-1beta/metabolism , Interleukins/metabolism , Intestines/drug effects , Mice , Mice, Inbred C57BL , Prostaglandin Antagonists/adverse effects , Prostaglandins/biosynthesis , Risk Factors , Weight Loss , Interleukin-22
2.
Article in English | MEDLINE | ID: mdl-28217556

ABSTRACT

Streptococcus agalactiae, or Group B Streptococcus (GBS), is a gram-positive bacterial pathogen associated with infection during pregnancy and is a major cause of morbidity and mortality in neonates. Infection of the extraplacental membranes surrounding the developing fetus, a condition known as chorioamnionitis, is characterized histopathologically by profound infiltration of polymorphonuclear cells (PMNs, neutrophils) and greatly increases the risk for preterm labor, stillbirth, or neonatal GBS infection. The advent of animal models of chorioamnionitis provides a powerful tool to study host-pathogen relationships in vivo and ex vivo. The purpose of this study was to evaluate the innate immune response elicited by GBS and evaluate how antimicrobial strategies elaborated by these innate immune cells affect bacteria. Our work using a mouse model of GBS ascending vaginal infection during pregnancy reveals that clinically isolated GBS has the capacity to invade reproductive tissues and elicit host immune responses including infiltration of PMNs within the choriodecidua and placenta during infection, mirroring the human condition. Upon interacting with GBS, murine neutrophils elaborate DNA-containing extracellular traps, which immobilize GBS and are studded with antimicrobial molecules including lactoferrin. Exposure of GBS to holo- or apo-forms of lactoferrin reveals that the iron-sequestration activity of lactoferrin represses GBS growth and viability in a dose-dependent manner. Together, these data indicate that the mouse model of ascending infection is a useful tool to recapitulate human models of GBS infection during pregnancy. Furthermore, this work reveals that neutrophil extracellular traps ensnare GBS and repress bacterial growth via deposition of antimicrobial molecules, which drive nutritional immunity via metal sequestration strategies.


Subject(s)
Extracellular Traps , Immunity, Innate , Mucous Membrane/pathology , Neutrophil Infiltration , Reproductive Tract Infections/pathology , Streptococcus agalactiae/pathogenicity , Animals , Anti-Bacterial Agents/metabolism , Disease Models, Animal , Female , Iron/metabolism , Lactoferrin/metabolism , Mice , Microbial Viability/drug effects , Mucous Membrane/immunology , Reproductive Tract Infections/immunology , Streptococcus agalactiae/immunology
3.
J Infect Dis ; 215(4): 653-657, 2017 02 15.
Article in English | MEDLINE | ID: mdl-27436434

ABSTRACT

Staphylococcus aureus, a metabolically flexible gram-positive pathogen, causes infections in a variety of tissues. Recent evidence implicates S. aureus as an emerging cause of chorioamnionitis and premature rupture of membranes, which are associated with preterm birth and neonatal disease. We demonstrate here that S. aureus infects and forms biofilms on the choriodecidual surface of explanted human gestational membranes. Concomitantly, S. aureus elicits the production of proinflammatory cytokines, which could ultimately perturb maternal-fetal tolerance during pregnancy. Therefore, targeting the immunological response to S. aureus infection during pregnancy could attenuate disease among infected individuals, especially in the context of antibiotic resistance.


Subject(s)
Chorioamnionitis/immunology , Cytokines/immunology , Pregnancy Complications, Infectious/immunology , Staphylococcal Infections/immunology , Biofilms , Chorioamnionitis/microbiology , Drug Resistance, Multiple, Bacterial , Female , Humans , Infant, Newborn , Placenta/immunology , Placenta/microbiology , Pregnancy , Pregnancy Complications, Infectious/microbiology , Premature Birth/immunology , Premature Birth/microbiology , Staphylococcus aureus/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...